From:
$21.05
93.42% OFF
Prescription required
Mesalamine DR: Uses, Dosage, Side Effects, and More
Reviewed by:
From:
$21.05
93.42% OFF
Prescription required
Mesalamine DR is a prescription medication used for the maintenance of remission in ulcerative colitis, a chronic inflammatory bowel disease affecting the lining of the colon. It is designed for long-term use to help keep symptoms under control in adults whose disease is already in remission.
Your Prescription
Ready to Fill
Your savings with us
93.42%
Avg. price at other pharmacies
$320.13
Need Help?
Our pharmacists are available 24/7 to answer questions about your medication.
Drug Facts
Generic name
Mesalamine delayed-release
Brand names
Apriso
Drug type
Aminosalicylate (5-ASA anti-inflammatory agent)
Controlled substance
Not a controlled medication
Dosage forms
Oral capsules
Typical dosage
Adults typically take 1.5 g by mouth once daily, administered as four 0.375 g delayed-release capsules, preferably in the morning. Capsules should be swallowed whole and not crushed or chewed. Skipping doses or discontinuing treatment may increase the risk of ulcerative colitis relapse.
Basics
What is Mesalamine DR?
Mesalamine DR refers to the delayed-release form of mesalamine. This formulation is crucial in ensuring that the drug reaches the specific areas of inflammation in the colon.
By bypassing the upper gastrointestinal tract and releasing the active ingredient in the colon, mesalamine DR effectively reduces inflammation associated with inflammatory bowel diseases such as ulcerative colitis. In doing so, it helps maintain remission and manage symptoms over the long term.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
What is Apriso?
Apriso is a medication specifically designed to manage certain gastrointestinal conditions, particularly ulcerative colitis. As a brand-name drug, Apriso contains mesalamine, an anti-inflammatory agent that targets inflammation within the colon.
This medication is provided as a delayed-release capsule, ensuring the active ingredient is delivered directly to the site of inflammation in the lower gastrointestinal tract. This targeted approach maximizes the drug’s effectiveness in alleviating symptoms associated with ulcerative colitis.
⚠️ Important Safety Warning:
Mesalamine can cause kidney and liver toxicity in rare cases. Patients should undergo regular renal and hepatic function tests during treatment, especially if they have pre-existing kidney or liver disease or are taking nephrotoxic drugs.
Indications
What Is Mesalamine DR Used For?
Apriso is primarily used to manage conditions associated with inflammatory bowel disease, particularly ulcerative colitis. Its efficacy in reducing colon inflammation makes it a valuable tool in the therapeutic arsenal against these conditions.
Primary Indications
- Maintenance therapy for ulcerative colitis: Apriso helps maintain remission and prevent flare-ups in individuals who have achieved remission.
- Treatment of mild to moderately active ulcerative colitis: It is also used to manage active symptoms in individuals with mild to moderate ulcerative colitis.
Off-Label Uses
- Management of Crohn’s disease: Although primarily indicated for ulcerative colitis, mesalamine may occasionally be employed off-label to manage symptoms associated with Crohn’s disease. However, its efficacy for Crohn’s disease is not as well established as in ulcerative colitis.
Apriso’s role in preventing relapse and managing active symptoms makes it a cornerstone in the treatment of ulcerative colitis. The delayed-release formulation ensures that the active ingredient is delivered directly to the affected areas within the colon, enhancing its effectiveness and minimizing systemic side effects.
Mechanism
How Does Mesalamine DR Work?
Apriso is formulated to deliver mesalamine directly to the colon, where it exerts its therapeutic effects by reducing inflammation. This targeted delivery is essential for the drug’s efficacy in treating inflammatory bowel diseases.
Mechanism of Action
Apriso works by releasing mesalamine in the colon. The active ingredient acts as an anti-inflammatory agent by inhibiting the production of certain inflammatory chemicals, particularly prostaglandins and leukotrienes, within the colon’s lining.
This action reduces inflammation, thereby alleviating symptoms such as pain, diarrhea, and rectal bleeding associated with ulcerative colitis.
Pharmacokinetics
Apriso is designed as a delayed-release capsule to ensure that mesalamine is not released until it reaches the colon. The capsule’s coating dissolves at a specific pH level found in the intestines, allowing a gradual release of the active ingredient.
This design facilitates extended delivery and prolonged action, maximizing the drug’s therapeutic impact while minimizing systemic absorption and potential side effects.
This pharmacokinetic profile ensures that mesalamine remains in the colon long enough to be effective, reducing the frequency of administration and improving patient compliance. By delivering medication where it is needed most, Apriso offers a targeted approach to managing ulcerative colitis.
Dosage
Mesalamine DR Dosages & Administration
Proper dosing and administration of Apriso are vital to its effectiveness in managing ulcerative colitis. Understanding the recommended dosages and the correct way to take the medication ensures its optimal use.
Dosage Recommendations
The typical adult dosage for Apriso consists of four 0.375g capsules taken orally once daily in the morning. This dosage is established to maintain consistent levels of the medication in the colon, ensuring sustained anti-inflammatory effects throughout the day.
Administration Guidelines
- With or without food: Apriso can be taken with or without food, providing flexibility for the patient.
- Capsule integrity: It is crucial that capsules be swallowed whole, without crushing or chewing. This ensures the delayed-release mechanism is not compromised.
- Swallowing considerations: For individuals with swallowing difficulties, consulting a healthcare provider for alternatives or solutions is advisable to ensure proper administration.
Maintaining the integrity of the capsules and adhering to the once-daily dosing schedule are key aspects of Apriso’s administration. These practices ensure the delayed-release mechanism functions correctly, enabling optimal therapeutic benefits in the management of ulcerative colitis.
Get The Right Dose For Less
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Mesalamine DR Side Effects and Risks
While Apriso is generally well-tolerated, as with all medications, it can cause side effects. Understanding the potential common and serious side effects enables patients and healthcare providers to better manage treatment and ensure safety.
Common Side Effects
- Headache: Some patients may experience mild to moderate headaches, particularly during the initial phase of treatment as the body adjusts.
- Nausea: This is one of the more commonly reported gastrointestinal side effects and may occur shortly after dosing.
- Diarrhea: This side effect may occur initially, especially early in therapy, as the digestive system adapts to the medication.
- Abdominal pain: Some individuals may experience mild to moderate abdominal discomfort or cramping during treatment.
Serious Side Effects
- Severe allergic reactions: Symptoms such as rash, itching, swelling of the face or throat, severe dizziness, or difficulty breathing require immediate medical attention.
- Liver dysfunction: Signs such as yellowing of the skin or eyes, dark-colored urine, persistent nausea, or vomiting should be promptly evaluated by a healthcare provider.
- Renal impairment: Symptoms may include changes in urine output, swelling, or abnormal kidney function tests, such as elevated creatinine levels, all of which warrant medical evaluation.
Being aware of these potential side effects and recognizing when to seek medical advice are crucial for safely managing treatment with Apriso. While serious side effects are rare, they require immediate attention to prevent complications.
Monitoring & Safety Considerations:
- Renal Function: Check serum creatinine and urinalysis periodically.
- Liver Function: Monitor liver enzymes in patients with hepatic impairment.
- Blood Counts: Rare cases of blood dyscrasias reported—monitor if symptoms occur.
- Allergic Reactions: Stop immediately if severe rash or hypersensitivity develops.
Interactions
Mesalamine DR Interactions
Understanding drug interactions is critical to ensuring the safe and effective use of Apriso. Interactions may alter how Apriso works or increase the risk of side effects.
Primary Drug Interactions
- Antacids: These can alter the pH-dependent release of mesalamine, potentially reducing the effectiveness of Apriso. It is advisable to separate antacid and Apriso dosing when possible.
- NSAIDs: Nonsteroidal anti-inflammatory drugs may increase the risk of renal impairment when used concurrently with Apriso, particularly with long-term use.
- Azathioprine or 6-MP: May increase risk of bone marrow suppression—monitor blood counts.
Other Considerations
- Nephrotoxic agents: Caution is advised when Apriso is used alongside other medications that can affect kidney function, as this may increase the risk of renal injury.
Discussing all current medications, including over-the-counter drugs and supplements, with a healthcare provider is crucial to avoid adverse interactions and ensure optimal therapeutic effect. Proper management of drug interactions helps maintain the efficacy and safety of Apriso treatment.
Contraindications
Mesalamine DR Contraindications
Identifying contraindications helps prevent the use of Apriso in situations where it may cause harm. Recognizing these contraindications and taking necessary precautions are essential for patient safety.
Absolute Contraindications
- Hypersensitivity: Any known allergy to mesalamine, salicylates, or related compounds should prevent the use of Apriso due to the risk of serious allergic reactions.
- Severe renal impairment: Patients with significant kidney dysfunction should avoid using Apriso, as impaired clearance may increase toxicity risk.
Warnings & Precautions
- Renal function monitoring: Regular kidney function assessments are recommended, especially for patients with pre-existing renal conditions or those taking other nephrotoxic medications.
- Liver disease: Patients with underlying liver disease should use Apriso cautiously and under close healthcare provider supervision, with periodic liver function testing as needed.
By understanding these constraints, patients and healthcare providers can ensure that Apriso is used safely, avoiding potential complications associated with these risks.
Ready to Start Saving?
No one should overpay for safe, effective medication. By cutting out middlemen and working directly with trusted, FDA-approved manufacturers, Invictus offers the same high-quality medicines you’d find at big retail pharmacies—at a fraction of the price.
Whether you choose brand-name or generic, we’ll deliver it quickly, affordably, and right to your door. Maybe that’s why most patients who switch to Invictus never look back.
Frequently Asked Questions (FAQs)
Didn’t see the answers you’re looking for in this article? Check out this comprehensive FAQ for more details.
Administration & Dosage
Apriso should be taken once daily, ideally in the morning. The capsule is designed to be swallowed whole to ensure proper release of the medication in the colon, maximizing its efficacy. Remember to take it consistently at the same time every day.
Apriso capsules should not be opened or crushed. They have a unique coating that allows for delayed release, ensuring the medication is properly delivered to the colon. Altering the capsule could impair this release mechanism, reducing the medication's effectiveness.
The typical dosage for adults is four 0.375g capsules taken once daily. Your healthcare provider might adjust this dose based on your specific medical requirements. Always adhere to your doctor’s instructions and never modify your dose without their guidance.
It's generally recommended to take Apriso in the morning. Taking it at the same time each day helps maintain consistent medication levels in your system, enhancing its effectiveness in managing ulcerative colitis symptoms.
Relief onset can vary among individuals, but many patients report noticing improvements in their gastrointestinal symptoms within several days of starting Apriso. Maintaining consistent use is essential for achieving optimal therapeutic benefits.
Uses & Mechanism of Action
Apriso is primarily used to maintain remission in patients with ulcerative colitis, a chronic inflammatory bowel disease. It helps reduce symptoms such as diarrhea and abdominal pain associated with this condition by targeting colon inflammation.
Apriso contains mesalamine, an anti-inflammatory agent that inhibits the production of substances in the colon that trigger inflammation and tissue damage. Doing so helps alleviate symptoms such as diarrhea and abdominal discomfort.
Apriso is not a steroid. It is categorized as an anti-inflammatory medication, specifically designed to treat gastrointestinal tract inflammation. This distinguishes it from corticosteroids, which have a broader immune-suppressing function.
Apriso does not function as an immunosuppressant. It targets inflammation locally within the colon without systematically suppressing the immune system, making it a safer option for long-term management of ulcerative colitis.
Mesalamine DR, or delayed-release mesalamine, is used to manage inflammation in the colon lining associated with ulcerative colitis and other inflammatory bowel diseases, offering targeted anti-inflammatory effects directly where needed.
Side Effects & Safety
Common side effects associated with Apriso include headache, nausea, diarrhea, and abdominal pain. If these symptoms persist or worsen over time, it is advisable to consult your healthcare provider for further evaluation and management.
Hair loss is not a commonly reported side effect of Apriso. Should you experience significant hair loss, it would be prudent to contact your doctor for an assessment, as it may be attributable to other health-related issues.
Weight gain is not typically associated with Apriso usage. Notable changes in weight might be more closely related to overall ulcerative colitis management or lifestyle factors than to a direct effect of the medication itself.
Serious side effects can include severe abdominal pain, exacerbation of ulcerative colitis symptoms, notable mood changes, and signs of kidney dysfunction. Should any of these occur, immediate consultation with your healthcare provider is essential.
The safety and efficacy of Apriso in children have not been conclusively established. Apriso should only be given to children under the guidance and prescription of a qualified pediatric gastroenterologist.
Interactions & Contraindications
Apriso might interact with other medications, including certain blood thinners and anti-inflammatory drugs. It is crucial to discuss your full list of medications and supplements with your healthcare provider to identify and prevent potential interactions.
Alcohol consumption is generally discouraged while taking Apriso, as it may exacerbate side effects or interfere with the drug's effectiveness. Discussing alcohol use with your healthcare provider can help tailor safe use recommendations.
Apriso should be used cautiously in individuals with existing kidney or liver issues. Your healthcare provider should thoroughly review your medical history to ensure Apriso is a safe option for your treatment plan.
The safety of Apriso during pregnancy has not been comprehensively established. Pregnant women should engage in detailed discussions with their healthcare providers to weigh potential benefits against any risks to the developing fetus.
While Apriso does not require food for effectiveness, taking mesalamine formulations like Lialda with food can aid absorption and reduce gastrointestinal discomfort, ensuring optimal therapeutic effect.
Generic & Alternatives
Mesalamine DR is a delayed-release form of mesalamine used in various formulations, like Apriso, to treat inflammatory bowel diseases. It delivers targeted colon-specific therapy, ensuring maximum anti-inflammatory impact where needed.
Generic versions of Apriso may be available depending on specific market regulations and production. Checking with pharmacies or your healthcare provider is the best way to get the most up-to-date information on the availability of generic alternatives.
The cost of Apriso can vary widely based on factors such as insurance coverage, pharmacy pricing, and whether a brand-name or generic version is purchased. Consulting a pharmacist can provide precise pricing details for your plan.
Coverage for mesalamine DR under Medicare can differ, with specifics regarding coverage and costs determined by individual Medicare Part D plans. Contacting your plan provider is necessary to verify exact coverage details and personal expenses.
Alternatives to Apriso may include other mesalamine products, such as Lialda and Asacol, or medications from other drug classes, such as corticosteroids and immunosuppressants. Healthcare providers can guide you to the most appropriate treatment option.
Disclaimer
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Your savings with us
93.42%
Avg. price at other pharmacies
$320.13
Need Help?
Our pharmacists are available 24/7 to answer questions about your medication.
